SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-008456
Filing Date
2024-01-31
Accepted
2024-01-31 16:25:03
Documents
2
Period of Report
2024-01-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4015
2 POWER OF ATTORNEY (THANI JAMBULINGAM) ea192540ex24-1_virpax.htm EX-24.1 6197
  Complete submission text file 0001213900-24-008456.txt   11749
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIRAX PHARMACEUTICALS, INC. 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address
Jambulingam Thani (Reporting) CIK: 0001818466 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40064 | Film No.: 24583268